09:46 AM EST - Chemokine Therapeutics Corp. : reported second-quarter net loss of US$863 thousand or US$0.02 per share, compared to net loss of US$306 thousand or US$0.01 per share last year. The company had no revenues in the three months ended June 30, 2008, as well as in the three months ended June 30, 2007. Chemokine Therapeutics Corp.
shares T.CTI are trading up 3 cents at $0.13.
